When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review BPC 157 Banned: Key Facts on the Latest FDA Decision The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step